STOCK TITAN

[Form 4] eHealth, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

eHealth CEO Francis S. Soistman Jr. reported a tax-related share withholding transaction on June 22, 2025. The Form 4 filing discloses the disposition of 1,709 shares of Common Stock at a price of $4.00 per share to satisfy tax withholding obligations.

Following the transaction, Soistman maintains direct beneficial ownership of 780,839 shares of eHealth Common Stock. The transaction was executed under transaction code 'F', indicating a payment of exercise price or tax withholding by delivering or withholding securities.

The reporting person serves as both Director and Chief Executive Officer of eHealth. The transaction was reported within the required filing deadline, with the Form 4 being filed on June 24, 2025, through an attorney-in-fact.

Il CEO di eHealth, Francis S. Soistman Jr., ha comunicato una transazione di ritenuta azionaria legata a imposte il 22 giugno 2025. La dichiarazione Form 4 rivela la cessione di 1.709 azioni ordinarie al prezzo di 4,00 $ per azione per adempiere agli obblighi di ritenuta fiscale.

Dopo la transazione, Soistman detiene direttamente la proprietà beneficiaria di 780.839 azioni ordinarie di eHealth. L’operazione è stata eseguita con il codice transazione 'F', che indica il pagamento del prezzo di esercizio o della ritenuta fiscale tramite consegna o trattenuta di titoli.

La persona che ha effettuato la segnalazione ricopre sia il ruolo di Direttore che Amministratore Delegato di eHealth. La transazione è stata comunicata entro i termini previsti, con la presentazione del Form 4 avvenuta il 24 giugno 2025 tramite un procuratore.

El CEO de eHealth, Francis S. Soistman Jr., informó una transacción de retención de acciones relacionada con impuestos el 22 de junio de 2025. La presentación del Formulario 4 revela la disposición de 1,709 acciones ordinarias a un precio de $4.00 por acción para cumplir con las obligaciones de retención fiscal.

Después de la transacción, Soistman mantiene la propiedad beneficiaria directa de 780,839 acciones ordinarias de eHealth. La transacción se realizó bajo el código 'F', que indica el pago del precio de ejercicio o la retención fiscal mediante la entrega o retención de valores.

La persona que reporta ocupa los cargos de Director y Director Ejecutivo de eHealth. La transacción fue reportada dentro del plazo requerido, presentando el Formulario 4 el 24 de junio de 2025 a través de un apoderado.

eHealth의 CEO Francis S. Soistman Jr.는 2025년 6월 22일 세금 관련 주식 원천징수 거래를 보고했습니다. Form 4 제출서에는 세금 원천징수 의무를 충족하기 위해 1,709주의 보통주를 주당 4.00달러에 처분한 내용이 공개되어 있습니다.

거래 후 Soistman은 eHealth 보통주 780,839주에 대한 직접적 실소유권을 유지하고 있습니다. 이 거래는 거래 코드 'F'로 실행되었으며, 이는 증권을 제공하거나 원천징수하여 행사 가격 또는 세금 원천징수를 지급했음을 나타냅니다.

보고자는 eHealth의 이사 겸 최고경영자(CEO)로 재직 중입니다. 거래는 요구된 제출 기한 내에 보고되었으며, Form 4는 2025년 6월 24일 법정대리인을 통해 제출되었습니다.

Le PDG d’eHealth, Francis S. Soistman Jr., a déclaré une opération de retenue d’actions liée à l’impôt le 22 juin 2025. Le dépôt du formulaire 4 révèle la cession de 1 709 actions ordinaires au prix de 4,00 $ par action pour satisfaire aux obligations de retenue fiscale.

Après la transaction, Soistman conserve la propriété bénéficiaire directe de 780 839 actions ordinaires d’eHealth. La transaction a été réalisée sous le code 'F', indiquant un paiement du prix d’exercice ou une retenue fiscale par livraison ou retenue de titres.

La personne déclarant est à la fois Directeur et Directeur Général d’eHealth. La transaction a été déclarée dans les délais requis, le formulaire 4 ayant été déposé le 24 juin 2025 par un mandataire.

eHealth CEO Francis S. Soistman Jr. meldete am 22. Juni 2025 eine aktienbezogene Steuerabzugs-Transaktion. Die Form 4 Einreichung offenbart die Veräußerung von 1.709 Stammaktien zu einem Preis von 4,00 $ pro Aktie, um Steuerabzugsverpflichtungen zu erfüllen.

Nach der Transaktion hält Soistman weiterhin das direkte wirtschaftliche Eigentum an 780.839 eHealth Stammaktien. Die Transaktion wurde unter dem Transaktionscode 'F' ausgeführt, was auf die Zahlung des Ausübungspreises oder des Steuerabzugs durch Lieferung oder Einbehaltung von Wertpapieren hinweist.

Die meldende Person ist sowohl Direktor als auch Chief Executive Officer von eHealth. Die Transaktion wurde fristgerecht gemeldet, wobei das Form 4 am 24. Juni 2025 über einen Bevollmächtigten eingereicht wurde.

Positive
  • None.
Negative
  • None.

Il CEO di eHealth, Francis S. Soistman Jr., ha comunicato una transazione di ritenuta azionaria legata a imposte il 22 giugno 2025. La dichiarazione Form 4 rivela la cessione di 1.709 azioni ordinarie al prezzo di 4,00 $ per azione per adempiere agli obblighi di ritenuta fiscale.

Dopo la transazione, Soistman detiene direttamente la proprietà beneficiaria di 780.839 azioni ordinarie di eHealth. L’operazione è stata eseguita con il codice transazione 'F', che indica il pagamento del prezzo di esercizio o della ritenuta fiscale tramite consegna o trattenuta di titoli.

La persona che ha effettuato la segnalazione ricopre sia il ruolo di Direttore che Amministratore Delegato di eHealth. La transazione è stata comunicata entro i termini previsti, con la presentazione del Form 4 avvenuta il 24 giugno 2025 tramite un procuratore.

El CEO de eHealth, Francis S. Soistman Jr., informó una transacción de retención de acciones relacionada con impuestos el 22 de junio de 2025. La presentación del Formulario 4 revela la disposición de 1,709 acciones ordinarias a un precio de $4.00 por acción para cumplir con las obligaciones de retención fiscal.

Después de la transacción, Soistman mantiene la propiedad beneficiaria directa de 780,839 acciones ordinarias de eHealth. La transacción se realizó bajo el código 'F', que indica el pago del precio de ejercicio o la retención fiscal mediante la entrega o retención de valores.

La persona que reporta ocupa los cargos de Director y Director Ejecutivo de eHealth. La transacción fue reportada dentro del plazo requerido, presentando el Formulario 4 el 24 de junio de 2025 a través de un apoderado.

eHealth의 CEO Francis S. Soistman Jr.는 2025년 6월 22일 세금 관련 주식 원천징수 거래를 보고했습니다. Form 4 제출서에는 세금 원천징수 의무를 충족하기 위해 1,709주의 보통주를 주당 4.00달러에 처분한 내용이 공개되어 있습니다.

거래 후 Soistman은 eHealth 보통주 780,839주에 대한 직접적 실소유권을 유지하고 있습니다. 이 거래는 거래 코드 'F'로 실행되었으며, 이는 증권을 제공하거나 원천징수하여 행사 가격 또는 세금 원천징수를 지급했음을 나타냅니다.

보고자는 eHealth의 이사 겸 최고경영자(CEO)로 재직 중입니다. 거래는 요구된 제출 기한 내에 보고되었으며, Form 4는 2025년 6월 24일 법정대리인을 통해 제출되었습니다.

Le PDG d’eHealth, Francis S. Soistman Jr., a déclaré une opération de retenue d’actions liée à l’impôt le 22 juin 2025. Le dépôt du formulaire 4 révèle la cession de 1 709 actions ordinaires au prix de 4,00 $ par action pour satisfaire aux obligations de retenue fiscale.

Après la transaction, Soistman conserve la propriété bénéficiaire directe de 780 839 actions ordinaires d’eHealth. La transaction a été réalisée sous le code 'F', indiquant un paiement du prix d’exercice ou une retenue fiscale par livraison ou retenue de titres.

La personne déclarant est à la fois Directeur et Directeur Général d’eHealth. La transaction a été déclarée dans les délais requis, le formulaire 4 ayant été déposé le 24 juin 2025 par un mandataire.

eHealth CEO Francis S. Soistman Jr. meldete am 22. Juni 2025 eine aktienbezogene Steuerabzugs-Transaktion. Die Form 4 Einreichung offenbart die Veräußerung von 1.709 Stammaktien zu einem Preis von 4,00 $ pro Aktie, um Steuerabzugsverpflichtungen zu erfüllen.

Nach der Transaktion hält Soistman weiterhin das direkte wirtschaftliche Eigentum an 780.839 eHealth Stammaktien. Die Transaktion wurde unter dem Transaktionscode 'F' ausgeführt, was auf die Zahlung des Ausübungspreises oder des Steuerabzugs durch Lieferung oder Einbehaltung von Wertpapieren hinweist.

Die meldende Person ist sowohl Direktor als auch Chief Executive Officer von eHealth. Die Transaktion wurde fristgerecht gemeldet, wobei das Form 4 am 24. Juni 2025 über einen Bevollmächtigten eingereicht wurde.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SOISTMAN FRANCIS S JR

(Last) (First) (Middle)
C/O EHEALTH, INC.
13620 RANCH ROAD 620 N, SUITE A250

(Street)
AUSTIN TX 78717

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
eHealth, Inc. [ EHTH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
06/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/22/2025 F(1) 1,709 D $4 780,839 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the withholding of shares to satisfy tax withholding obligation.
Remarks:
/s/ Sonwha Lee as attorney-in-fact for Francis S. Soistman 06/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Ehealth Inc

NASDAQ:EHTH

EHTH Rankings

EHTH Latest News

EHTH Latest SEC Filings

EHTH Stock Data

121.31M
28.18M
5.22%
68.32%
0.77%
Insurance Brokers
Insurance Agents, Brokers & Service
Link
United States
AUSTIN